Samfara has completed the acquisition of Chr. Olesen Synthesis from Chr. Olesen and funds managed by Signet Healthcare Partners, marking the European life sciences investment firm's first investment.
Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "Peptide Synthesis Market Industry Trends and Global Forecasts to 2035, by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract ...
With the healthcare landscape continually evolving, the generic medicines industry guarantees widespread access to affordable medications for millions of patients worldwide. Generics play a pivotal ...
INTRODUCTION Over the years, the popularity of biologics has led to an evident shift in the focus of pharmaceutical companies, from traditional interventions towards more complex and advanced ...
Green-by-design API synthesis does not occur in a vacuum. “Optimization of the way drugs are prepared sits side-by-side with the robustness needed to manufacture a drug with the quality, consistency, ...
Syngene had successfully demonstrated the small-scale synthesis of a novel vascular calcification inhibitor API from lab-scale to tox-batch manufacturing. This was following the request of a pharma ...
Chemical process development bridges drug discovery and active pharmaceutical ingredient (API) manufacturing by enabling rapid, safe, sustainable, and cost-effective access to new chemical modalities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results